The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Drug-induced mitochondrial dysfunction and cardiotoxicity
Open accessAbstract
Mitochondria has an essential role in myocardial tissue homeostasis; thus deterioration in mitochondrial function eventually leads to cardiomyocyte and endothelial cell death and consequent cardiovascular dysfunction. Several chemical compounds and drugs have been known to directly or indirectly modulate cardiac mitochondrial function, which can account both for the toxicological and pharmacological properties of these substances. In many cases, toxicity problems appear only in the presence of additional cardiovascular disease conditions or develop months/years following the exposure, making the diagnosis difficult. Cardiotoxic agents affecting mitochondria include several widely used anticancer drugs [anthracyclines (Doxorubicin/Adriamycin), cisplatin, trastuzumab (Herceptin), arsenic trioxide (Trisenox), mitoxantrone (Novantrone), imatinib (Gleevec), bevacizumab (Avastin), sunitinib (Sutent), and sorafenib (Nevaxar)], antiviral compound azidothymidine (AZT, Zidovudine) and several oral antidiabetics [e.g., rosiglitazone (Avandia)]. Illicit drugs such as alcohol, cocaine, methamphetamine, ecstasy, and synthetic cannabinoids (spice, K2) may also induce mitochondria-related cardiotoxicity. Mitochondrial toxicity develops due to various mechanisms involving interference with the mitochondrial respiratory chain (e.g., uncoupling) or inhibition of the important mitochondrial enzymes (oxidative phosphorylation, Szent-Györgyi-Krebs cycle, mitochondrial DNA replication, ADP/ATP translocator). The final phase of mitochondrial dysfunction induces loss of mitochondrial membrane potential and an increase in mitochondrial oxidative/nitrative stress, eventually culminating into cell death. This review aims to discuss the mechanisms of mitochondrion-mediated cardiotoxicity of commonly used drugs and some potential cardioprotective strategies to prevent these toxicities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, S., & Ren, J. T. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.02.276 · Cited by 100
RetractedSlamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Self-citationControl of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., De Smedt, H., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,120
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Doxorubicin-Induced Cardiomyopathy
Singal, P. K., & Iliskovic, N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391307 · Cited by 1,845
A clinicopathologic analysis of adriamycin cardiotoxicity
Lefrak, E. A., Piťha, J., Rosenheim, S., & Gottlieb, J. A. (1973) · Cancer · doi:10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2 · Cited by 1,560
Reactive Oxygen Species (Ros-Induced) Ros Release
Zorov, D. B., Filburn, C. R., Klotz, L.-O., Zweier, J. L., & Sollott, S. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1001 · Cited by 1,412
Miller, K. D., Chap, L. I., Holmes, F. A., Cobleigh, M. A., Marcom, P. K., Fehrenbacher, L., Dickler, M., Overmoyer, B. A., Reimann, J. D., Sing, A. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.098 · Cited by 1,306
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
Deininger, M., Buchdunger, E., & Druker, B. J. (2005) · Blood · doi:10.1182/blood-2004-08-3097 · Cited by 1,253
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Kerkelä, R., Grazette, L., Yacobi, R., Iliescu, C., Patten, R., Beahm, C., Walters, B., Shevtsov, S., Pesant, S., Clubb, F. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1446 · Cited by 1,159
Mitochondrial Dynamics — Mitochondrial Fission and Fusion in Human Diseases
Archer, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215233 · Cited by 1,102
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Chu, T. F., Rupnick, M. A., Kerkela, R., Dallabrida, S. M., Zurakowski, D., Nguyen, L., Woulfe, K., Pravda, E., Cassiola, F., Desai, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61865-0 · Cited by 1,083
Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Steinherz, L. J. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470120074036 · Cited by 989
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
James, W. P. T., Caterson, I. D., Coutinho, W., Finer, N., Van Gaal, L. F., Maggioni, A. P., Torp-Pedersen, C., Sharma, A. M., Shepherd, G. M., Rode, R. A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003114 · Cited by 943 · cited 1×
“vated receptor- (PPAR ) agonist antidiabetic drug rosiglitazone (Avandia; 2011)] (50, 62, 108).”
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 878
Ferdinandy, P., Schulz, R., & Baxter, G. F. (2007) · Pharmacological Reviews · doi:10.1124/pr.107.06002 · Cited by 744
Self-citationScirica, B. M., Braunwald, E., Raz, I., Cavender, M. A., Morrow, D. A., Jarolim, P., Udell, J. A., Mosenzon, O., Im, K., Umez-Eronini, A. A., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.010389 · Cited by 725
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Anthrazykline in der Krebstherapie: Ein Überblick
Hortobágyi, G. N. (1997) · Drugs · doi:10.2165/00003495-199700544-00003 · Cited by 678
Peroxynitrite reactions and formation in mitochondria
Radi, R., Cassina, A., Hodara, R., Quijano, C., & Castro, L. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01111-5 · Cited by 635
Davies, K. J., & Doroshow, J. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35746-0 · Cited by 631
Lipshultz, S. E., Rifai, N., Dalton, V. M., Levy, D. E., Silverman, L. B., Lipsitz, S. R., Colan, S. D., Asselin, B. L., Barr, R. D., Clavell, L. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035153 · Cited by 623
Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius
Arcamone, F., Cassinelli, G., Fantini, G., Grein, A., Orezzi, P., Pol, C., & Spalla, C. (1969) · Biotechnology and Bioengineering · doi:10.1002/bit.260110607 · Cited by 622
Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Schmidinger, M., Zielinski, C. C., Vogl, U. M., Bojic, A., Bojic, M., Schukro, C., Ruhsam, M., Hejna, M., & Schmidinger, H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6331 · Cited by 615
Ferdinandy, P., Hausenloy, D. J., Heusch, G., Baxter, G. F., & Schulz, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008300 · Cited by 562
Self-citationAlcohol and mitochondria: a dysfunctional relationship
Hoek, J. B., Cahill, A., & Pastorino, J. G. (2002) · Gastroenterology · doi:10.1053/gast.2002.33613 · Cited by 553
Doroshow, J. H., & Davies, K. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35747-2 · Cited by 540
Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?
Kerbel, R. S. (2006) · Science · doi:10.1126/science.1125950 · Cited by 466
Yen, H. C., Oberley, T. D., Vichitbandha, S., Ho, Y. S., & St Clair, D. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118909 · Cited by 459
The significance of mitochondrial toxicity testing in drug development
Dykens, J. A., & Will, Y. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.013 · Cited by 416
CaMKII determines mitochondrial stress responses in heart
Joiner, M.-L. A., Koval, O. M., Li, J., He, B. J., Allamargot, C., Gao, Z., Luczak, E. D., Hall, D. D., Fink, B. D., Chen, B., et al. (2012) · Nature · doi:10.1038/nature11444 · Cited by 409
Adriamycin-induced oxidative mitochondrial cardiotoxicity
Berthiaume, J. M., & Wallace, K. B. (2007) · Cell Biology and Toxicology · doi:10.1007/s10565-006-0140-y · Cited by 409
Mukhopadhyay, P., Rajesh, M., Bátkai, S., Kashiwaya, Y., Haskó, G., Liaudet, L., Szabó, C., & Pacher, P. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2008 · Cited by 376
Self-citationCytochrome c Nitration by Peroxynitrite
Cassina, A. M., Hodara, R., Souza, J. M., Thomson, L., Castro, L., Ischiropoulos, H., Freeman, B. A., & Radi, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909978199 · Cited by 354
Simple quantitative detection of mitochondrial superoxide production in live cells
Mukhopadhyay, P., Rajesh, M., Yoshihiro, K., Haskó, G., & Pacher, P. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.106 · Cited by 328
Self-citationPacher, P., & Szabó, C. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00018.x · Cited by 316
Self-citationAcute Binge Drinking Increases Serum Endotoxin and Bacterial DNA Levels in Healthy Individuals
Bala, S., Marcos, M., Gattu, A., Catalano, D., & Szabo, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096864 · Cited by 311
Armstrong, G. T., Joshi, V. M., Ness, K. K., Marwick, T. H., Zhang, N., Srivastava, D., Griffin, B. P., Grimm, R. A., Thomas, J., Phelan, D., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.013 · Cited by 303
Kang, Y. J., Chen, Y., & Epstein, P. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12610 · Cited by 303
Varga, Z. V., Giricz, Z., Liaudet, L., Haskó, G., Ferdinandy, P., & Pacher, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.030 · Cited by 286
Self-citationPacher, P., Liaudet, L., Bai, P., Mabley, J. G., Kaminski, P. M., Virág, L., Deb, A., Szabó, E., Ungvári, Z., Wolin, M. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000048192.52098.dd · Cited by 279
Self-citationPhase I and preliminary phase II evaluation of adriamycin (NSC 123127).
Bonadonna, G., Monfardini, S., Lena, M. D., Fossati‐Bellani, F., & Beretta, G. (1970) · PubMed · Cited by 278
Petit, T., Wilt, M., Velten, M., Millon, R., Rodier, J.-F., Borel, C., Mors, R., Haegelé, P., Eber, M., & Ghnassia, J.-P. (2004) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00675-0 · Cited by 264
Capranico, G., Tinelli, S., Austin, C. A., Fisher, M. L., & Zunino, F. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90050-a · Cited by 258
Kang, Y. J., Chen, Y., Yu, A., Voss-McCowan, M., & Epstein, P. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119672 · Cited by 253
Cardiovascular safety of sulfonylureas: a meta‐analysis of randomized clinical trials
Monami, M., Genovese, S., & Mannucci, E. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12116 · Cited by 251
Mitochondrial quality control: An integrated network of pathways
Fischer, F., Hamann, A., & Osiewacz, H. D. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.02.004 · Cited by 248
Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol.
Lange, L. G., & Sobel, B. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111022 · Cited by 248
Loke, Y. K., Kwok, C. S., & Singh, S. (2011) · BMJ · doi:10.1136/bmj.d1309 · Cited by 245
Kerkela, R., Woulfe, K. C., Durand, J., Vagnozzi, R., Kramer, D., Chu, T. F., Beahm, C., Chen, M. H., & Force, T. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00090.x · Cited by 242
Oxidation of CaMKII determines the cardiotoxic effects of aldosterone
He, B. J., Joiner, M.-L. A., Singh, M. V., Luczak, E. D., Swaminathan, P. D., Koval, O. M., Kutschke, W., Allamargot, C., Yang, J., Guan, X., et al. (2011) · Nature Medicine · doi:10.1038/nm.2506 · Cited by 240
Nitrosative stress and pharmacological modulation of heart failure
Pacher, P., Schulz, R., Liaudet, L., & Szabó, C. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.003 · Cited by 237
Self-citationMolecular Pharmacology of the Interaction of Anthracyclines with Iron
Xu, X., Persson, H. L., & Richardson, D. R. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013383 · Cited by 235
Protein Tyrosine Nitration in the Mitochondria from Diabetic Mouse Heart
Turko, I. V., Li, L., Aulak, K. S., Stuehr, D. J., Chang, J.-Y., & Murad, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303734200 · Cited by 225
Essential Roles of Her2/erbB2 in Cardiac Development and Function
Negro, A. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.1 · Cited by 220
Knight-Lozano, C. A., Young, C. G., Burow, D. L., Hu, Z. Y., Uyeminami, D., Pinkerton, K. E., Ischiropoulos, H., & Ballinger, S. W. (2002) · Circulation · doi:10.1161/hc0702.103977 · Cited by 217
Oxidatively damaged proteins of heart mitochondrial electron transport complexes
Choksi, K. B., Boylston, W. H., Rabek, J. P., Widger, W. R., & Papaconstantinou, J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.11.007 · Cited by 212
Mukhopadhyay, P., Horváth, B., Zsengellér, Z., Zielonka, J., Tanchian, G., Holovac, E., Kechrid, M., Patel, V., Stillman, I. E., Parikh, S. M., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.001 · Cited by 209
Self-citationMukhopadhyay, P., Bátkai, S., Rajesh, M., Czifra, N., Harvey-White, J., Haskó, G., Zsengeller, Z., Gerard, N. P., Liaudet, L., Kunos, G., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.057 · Cited by 207
Self-citationSide Effects of Cocaine Abuse: Multiorgan Toxicity and Pathological Consequences
Riezzo, I., Fiore, C., De Carlo, D., Pascale, N., Neri, M., Turillazzi, E., & Fineschi, V. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803988893 · Cited by 205
Will, Y., Dykens, J. A., Nadanaciva, S., Hirakawa, B., Jamieson, J., Marroquin, L. D., Hynes, J., Patyna, S., & Jessen, B. A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn157 · Cited by 205
Mukhopadhyay, P., Rajesh, M., Bátkai, S., Patel, V., Kashiwaya, Y., Liaudet, L., Evgenov, O. V., Mackie, K., Haskó, G., & Pacher, P. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp369 · Cited by 200
Self-citationDolce, V., Fiermonte, G., Runswick, M. J., Palmieri, F., & Walker, J. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031430998 · Cited by 195
Pacher, P., Liaudet, L., Bai, P., Virag, L., Mabley, J. G., Haskó, G., & Szabó, C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.862 · Cited by 188
Self-citationKubli, D. A., Quinsay, M. N., Huang, C., Lee, Y., & Gustafsson, Å. B. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00552.2008 · Cited by 187
Stress-responsive regulation of mitochondria through the ER unfolded protein response
Rainbolt, T. K., Saunders, J. M., & Wiseman, R. L. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.007 · Cited by 185
Trastuzumab-induced cardiac dysfunction: A 'dual-hit'.
Zeglinski, M. R., Lüdke, A., Jassal, D. S., & Singal, P. K. (2011) · Europe PMC (PubMed Central) · Cited by 181
Hao, E., Mukhopadhyay, P., Cao, Z., Erdélyi, K., Holovac, E., Liaudet, L., Lee, W.-S., Haskó, G., Mechoulam, R., & Pacher, P. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00261 · Cited by 176
Self-citationOxidative Post-translational Modification of Tryptophan Residues in Cardiac Mitochondrial Proteins
Taylor, S. W., Fahy, E., Murray, J., Capaldi, R. A., & Ghosh, S. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300135200 · Cited by 172
Varga, Z. V., Kupai, K., Szűcs, G., Gáspár, R., Pálóczi, J., Faragó, N., Zvara, Á., Puskás, L. G., Rázga, Z., Tiszlavicz, L., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.05.009 · Cited by 171
Self-citationSulphonylureas and risk of cardiovascular disease: systematic review and meta‐analysis
Phung, O. J., Schwartzman, E., Allen, R. W., Engel, S. S., & Rajpathak, S. N. (2013) · Diabetic Medicine · doi:10.1111/dme.12232 · Cited by 170
The role of iron in doxorubicin-induced cardiomyopathy.
Myers, C. (1998) · PubMed · Cited by 168
Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity
Liaudet, L., Calderari, B., & Pacher, P. (2014) · Heart Failure Reviews · doi:10.1007/s10741-014-9418-y · Cited by 166
Self-citationNadanaciva, S., Dykens, J. A., Bernal, A., Capaldi, R. A., & Will, Y. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.06.003 · Cited by 166
Oxidative Stress and Apoptosis in Heart Dysfunction
Kumar, D., Lou, H., & Singal, P. K. (2002) · Herz · doi:10.1007/s00059-002-2430-3 · Cited by 164
Redox Regulation of Mitochondrial ATP Synthase: Implications for Cardiac Resynchronization Therapy
Wang, S.-B., Foster, D. B., Rucker, J., O'Rourke, B., Kass, D. A., & Van Eyk, J. E. (2011) · Circulation Research · doi:10.1161/circresaha.111.246124 · Cited by 161
Serrano, J., Palmeira, C. M., Kuehl, D. W., & Wallace, K. B. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00011-0 · Cited by 159
Lewis, W., Simpson, J. F., & Meyer, R. R. (1994) · Circulation Research · doi:10.1161/01.res.74.2.344 · Cited by 153
ElZarrad, M. K., Mukhopadhyay, P., Mohan, N., Hao, E., Dokmanovic, M., Hirsch, D. S., Shen, Y., Pacher, P., & Wu, W. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079543 · Cited by 146
Self-citationRohrbach, S., Yan, X., Weinberg, E. O., Hasan, F., Bartúnek, J., Marchionni, M. A., & Lorell, B. H. (1999) · Circulation · doi:10.1161/01.cir.100.4.407 · Cited by 145
Baseler, W. A., Dabkowski, E. R., Williamson, C. L., Croston, T. L., Thapa, D., Powell, M. J., Trust T. Razunguzwa, & Hollander, J. M. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00423.2010 · Cited by 145
Lebrecht, D., Geist, A., Ketelsen, U., Haberstroh, J., Setzer, B., & Walker, U. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707294 · Cited by 136
Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer
Kerr, D. J., Dunn, J., Langman, M. J. S., Smith, J. L., Midgley, R. S., Stanley, A., Stokes, J. C., Julier, P., Iveson, C., Duvvuri, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071841 · Cited by 133
Quantitative Protein Profiling in Heart Mitochondria from Diabetic Rats
Turko, I. V., & Murad, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303139200 · Cited by 131
Acute kidney injury associated with smoking synthetic cannabinoid
Buser, G. L., Gerona, R. R. L., Horowitz, B. Z., Vian, K., Troxell, M. L., Hendrickson, R. G., Houghton, D. C., Rozansky, D. J., Su, S. W., & Leman, R. F. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.932365 · Cited by 130
Rosiglitazone for type 2 diabetes mellitus
Richter, B., Bandeira-Echtler, E., Bergerhoff, K., Clar, C., & Ebrahim, S. H. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006063.pub2 · Cited by 129
Hasinoff, B. B., Patel, D., & O’Hara, K. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050104 · Cited by 126
Zsengellér, Z. K., Ellezian, L., Brown, D. A., Horváth, B., Mukhopadhyay, P., Kalyanaraman, B., Parikh, S. M., Karumanchi, S. A., Stillman, I. E., & Pacher, P. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412446227 · Cited by 125
Self-citationCardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation
Young, A. C., Schwarz, E. S., Medina, G., Obafemi, A. I., Feng, S., Kane, C., & Kleinschmidt, K. (2011) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2011.05.013 · Cited by 121
Alcohol Effects on Cardiac Function
Gardner, J. D., & Mouton, A. J. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140046 · Cited by 120
Molecular and Cellular Mechanisms of Cardiotoxicity
Kang, Y. J. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109s127 · Cited by 118
Ma, H., Jones, K. R., Guo, R., Xu, P., Shen, Y., & Ren, J. T. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05323.x · Cited by 116
Liu, B., Tewari, A. K., Zhang, L., Green‐Church, K. B., Zweier, J. L., Chen, Y., & He, G. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.12.008 · Cited by 115
Mihm, M. J., Yu, F., Weinstein, D. M., Reiser, P. J., & Bauer, J. A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704495 · Cited by 115
Mitochondrial Topoisomerase I is Critical for Mitochondrial Integrity and Cellular Energy Metabolism
Douarre, C., Sourbier, C., Rosa, I. D., Das, B. B., Redon, C. E., Zhang, H., Neckers, L., & Pommier, Y. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041094 · Cited by 114
Kantarjian, H. M., O'Brien, S. M., Cortes, J. E., Giles, F. J., Rios, M. B., Shan, J., Faderl, S. H., Garcia‐Manero, G., Ferrajoli, A., Verstovšek, S., et al. (2003) · Cancer · doi:10.1002/cncr.11831 · Cited by 113
Mitochondrial protein tyrosine nitration
Castro, L., Demicheli, V., Tórtora, V., & Radí, R. (2010) · Free Radical Research · doi:10.3109/10715762.2010.516254 · Cited by 112
Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice.
Pollard, K. M., Pearson, D. L., Hultman, P. A., et al. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.0110927 · Cited by 111
Zhao, Y., Miriyala, S., Miao, L., Mitov, M. I., Schnell, D., Dhar, S. K., Cai, J., Klein, J. B., Rukhsana Sultana, A., Butterfield, D. A., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.001 · Cited by 110
Tan, Y., Li, X., Prabhu, S. D., Brittian, K. R., Chen, Q., Yin, X., McClain, C. J., Zhou, Z., & Cai, L. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.034 · Cited by 105
Sverdlov, A. L., Elezaby, A., Behring, J. B., Bachschmid, M. M., Luptak, I., Tu, V. H., Siwik, D. A., Miller, E. J., Liesa, M., Shirihai, O. S., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.07.018 · Cited by 103
Cardiotoxicity: Cisplatin and long-term cancer survivors
Patanè, S. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.238 · Cited by 102
Tomiyama, K., & Funada, M. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.028 · Cited by 96
Redox Balance and Carbonylated Proteins in Limb and Heart Muscles of Cachectic Rats
Marín‐Corral, J., de Oliveira, C. C. F., Pascual-Guàrdia, S., Sanchez, F., Oliván, M., Argilés, J. M. A., Busquets, S., López-Soriano, F. J., & Barreiro, E. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2818 · Cited by 95
Guo, W., Adachi, T. K., Matsui, R., Xu, S., Jiang, B., Zou, M., Kirber, M. T., Lieberthal, W., & Cohen, R. A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00096.2003 · Cited by 95
Forst, T. M., Hanefeld, M., Jacob, S., Moeser, G., Schwenk, G., Pfützner, A., & Haupt, A. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112465442 · Cited by 90
Redox Regulation of Mitochondrial ATP Synthase
Wang, S.-B., Murray, C. I., Chung, H. S., & Eyk, J. E. V. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.08.005 · Cited by 88
Barile, M., Valenti, D., Passarella, S., & Quagliariello, E. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00831-3 · Cited by 87
A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid
Takematsu, M., Hoffman, R. S., Nelson, L. S., Schechter, J., Moran, J. H., & Wiener, S. W. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.958614 · Cited by 83
Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury
Mukhopadhyay, P., Horváth, B., Rajesh, M., Matsumoto, S., Saito, K., Bátkai, S., Patel, V., Tanchian, G., Gao, R. Y., Cravatt, B. F., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.002 · Cited by 80
Self-citationAutophagy plays an important role in Sunitinib-mediated cell death in H9c2 cardiac muscle cells
Zhao, Y., Xue, T., Yang, X., Zhu, H., Ding, X., Lou, L., Lu, W. P., Yang, B., & He, Q. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.07.007 · Cited by 80
Pacher, P., Liaudet, L., Mabley, J. G., Cziráki, A., Haskó, G., & Szabó, C. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.2.369 · Cited by 79
Self-citationOxidative stress contributes to methamphetamine-induced left ventricular dysfunction
Lord, K. C., Shenouda, S. K., McIlwain, E., Charalampidis, D., Lucchesi, P. A., & Varner, K. J. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq043 · Cited by 77
S-nitrosation of mitochondrial connexin 43 regulates mitochondrial function
Soetkamp, D., Nguyen, T. T. M., Menazza, S., Hirschhäuser, C., Hendgen-Cotta, U. B., Rassaf, T., Schlüter, K., Boengler, K., Murphy, E., & Schulz, R. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0433-x · Cited by 76
Arsenic Trioxide‐Induced Apoptosis in H9c2 Cardiomyocytes: Implications in Cardiotoxicity
Zhao, X., Feng, T., Chen, H., Shan, H., Zhang, Y., Lu, Y., & Yang, B. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00150.x · Cited by 75
Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity
Bai, P., Mabley, J. G., Liaudet, L., Virág, L., Szabó, C., & Pacher, P. (2004) · Oncology Reports · doi:10.3892/or.11.2.505 · Cited by 74
Self-citationAlcoholic and Cocaine-Associated Cardiomyopathies
Awtry, E. H., & Philippides, G. J. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.11.004 · Cited by 73
Primary Prevention of Coronary Heart Disease
Maher, V. M. G., Sinfuego, J., Chao, P., & Parekh, J. (1997) · Drugs · doi:10.2165/00003495-199754010-00001 · Cited by 73
Differential Effects of Peroxynitrite on Human Mitochondrial Creatine Kinase Isoenzymes
Wendt, S., Schlattner, U., & Wallimann, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208572200 · Cited by 71
Wiebelhaus, J. M., Poklis, J. L., Poklis, A., Vann, R. E., Lichtman, A. H., & Wise, L. E. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.05.034 · Cited by 69
Vergeade, A., Mulder, P. G. H., Vendeville, C., Estour, F., Fortin, D., Ventura‐Clapier, R., Thuillez, C., & Monteil, C. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.05.024 · Cited by 67
Mashayekhi, V., Eskandari, M. R., Kobarfard, F., Khajeamiri, A. R., & Hosseini, M. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0919-3 · Cited by 64
Dickey, J. S., Gonzalez, Y., Aryal, B., Mog, S., Nakamura, A. J., Redon, C. E., Baxa, U., Rosen, E., Cheng, G., Zielonka, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070575 · Cited by 60 · cited 1×
“Consistently with the importance of mitochondrial ROS generation in the cardiotoxicity of doxorubicin, mitochondriatargeted antioxidants mito-tempol and MitoQ exerted cardioprotective effects in rodents without interfering with doxorubicin’s antitumor effect (24).”
Kohler, J. J., Cucoranu, I. C., Fields, E. J., Green, E., He, S., Hoying‐Brandt, A., Russ, R. B., Abuin, A., Johnson, D., Hosseini, S. H., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.39 · Cited by 60
Guo, J., Guo, Q., Fang, H., Lei, L., Zhang, T., Zhao, J., & Peng, S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.017 · Cited by 59
Görbe, A., Varga, Z. V., Kupai, K., et al. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01242.2010 · Cited by 59
Self-citationMitochondrial Dysfunction and Oxidative Damage to Sarcomeric Proteins
Bayeva, M., & Ardehali, H. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0149-8 · Cited by 57
Hajj, E. C. E., Hajj, M. C. E., Voloshenyuk, T. G., Mouton, A. J., Khoutorova, E., Molina, P. E., Gilpin, N. W., & Gardner, J. D. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12239 · Cited by 56
Peroxynitrite-induced inhibition and nitration of cardiac myofibrillar creatine kinase
Mihm, M. J., & Bauer, J. A. (2002) · Biochimie · doi:10.1016/s0300-9084(02)00005-6 · Cited by 55
Kumar, V., Kitaeff, N., Hampton, M. B., Cannell, M. B., & Winterbourn, C. C. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.02.018 · Cited by 48
Impaired dynamics and function of mitochondria caused by mtDNA toxicity leads to heart failure
Lauritzen, K. H., Kleppa, L., Aronsen, J. M., Eide, L., Carlsen, H., Haugen, Ø. P., Sjaastad, I., Klungland, A., Rasmussen, L. J., Attramadal, H., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00253.2014 · Cited by 48
Mitochondria play a critical role in cardioprotection
Marín-García, J., & Goldenthal, M. J. (2004) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(03)00129-5 · Cited by 47
Vendemiale, G., Grattagliano, I., Altomare, E., Serviddio, G., Portincasa, P., Prigigallo, F., & Palasciano, G. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00401-5 · Cited by 47
Madonna, R., Dessalvi, C. C., Deidda, M., Mele, D., Monte, I. P., Novo, G., Pagliaro, P., Pepe, A., Spallarossa, P., Tocchetti, C. G., et al. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9497-4 · Cited by 47
Hu, C., Ge, F., Hyodo, E., Arai, K., Iwata, S., Lobdell, H., Walewski, J. L., Zhou, S., Clugston, R. D., Jiang, H., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.02.005 · Cited by 46
Mitochondrial Cumulative Damage Induced by Mitoxantrone: Late Onset Cardiac Energetic Impairment
Rossato‐Grando, L. G., Costa, V. M., Dallegrave, E., Arbo, M. D., Silva, R., Ferreira, R. M., Amado, F. M. L., Dinis‐Oliveira, R. J., Duarte, J. A., Bastos, M. D. L., et al. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9230-2 · Cited by 46
Zhang, R.-H., Gao, J., Guo, H.-T., Scott, G. I., Eason, A. R., Wang, X., & Ren, J. T. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.08.014 · Cited by 44
Pacher, P. (2010) · Molecular Medicine Reports · doi:10.3892/mmr.2010.390 · Cited by 43
Self-citationAgeing is a Risk Factor in Imatinib Mesylate Cardiotoxicity
Maharsy, W. M., Aries, A., Mansour, O., Komati, H., & Nemer, M. J. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.58 · Cited by 42
Hoffmann, B. R., El‐Mansy, M. F., Sem, D. S., & Greene, A. S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301204r · Cited by 41
Multiple mechanisms underlying troglitazone-induced mitochondrial permeability transition
Okuda, T., Norioka, M., Shitara, Y., & Horie, T. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.08.007 · Cited by 41
Vergeade, A., Mulder, P. G. H., Vendeville, C., Ventura‐Clapier, R., Thuillez, C., & Monteil, C. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318271223c · Cited by 41
Rossato‐Grando, L. G., Costa, V. M., Vilas‐Boas, V., Bastos, M. D. L., Rolo, A. P., Palmeira, C. M., & Remião, F. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9224-0 · Cited by 37
Lang, C. H., & Korzick, D. H. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00414.2013 · Cited by 37
Lattanzio, F. A., Tiangco, D. A., Osgood, C. J., Beebe, S. J., Kerry, J. A., & Hargrave, B. (2005) · Cardiovascular Toxicology · doi:10.1385/ct:5:4:377 · Cited by 35
Ecstasy produces left ventricular dysfunction and oxidative stress in rats
Shenouda, S. K., Lord, K. C., McIlwain, E., Lucchesi, P. A., & Varner, K. J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn129 · Cited by 35
Lee, Y. H., Goh, W. W. B., Ng, C. K., Raida, M., Wong, L., Lin, Q., Boelsterli, U. A., & Chung, M. C. M. (2013) · Journal of Proteome Research · doi:10.1021/pr400219s · Cited by 34
Schroeder, P. E., & Hasinoff, B. B. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005546 · Cited by 33
Eaton, S. D., Fukumoto, K., Stefanutti, G., Spitz, L., Zammit, V. A., & Pierro, A. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311133 · Cited by 32
Watanabe, M., Funakoshi, T., Unuma, K., Aki, T., & Uemura, K. (2014) · Toxicology · doi:10.1016/j.tox.2014.04.008 · Cited by 31
Cong, W., Zhao, T., Zhu, Z., Huang, B., Ma, W., Wang, Y., Tan, Y., Chakrabarti, S., Li, X., Jin, L., et al. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.12.007 · Cited by 31
Wang, Y., Peng, F., Tong, W., Sun, H., Xu, N., & Liu, S. (2010) · Journal of Proteome Research · doi:10.1021/pr100349g · Cited by 30
Kaplán, P., Tatarková, Z., Račay, P., Lehotský, J., Pavlikova, M., & Dobrota, D. (2007) · Redox Report · doi:10.1179/135100007x200308 · Cited by 29
Guo, K. K., & Ren, J. T. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00215.x · Cited by 25
Liao, X., Wang, Y., & Wong, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00900.x · Cited by 22
Szentandrássy, N., Harmati, G., Bárándi, L., Simkó, J., Horváth, B., Magyar, J., Bányász, T., Lőrincz, I., Szebeni, A., Kecskeméti, V., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01215.x · Cited by 16
Sarraf, M., Lu, L., Ye, S., Reiter, M. J., Greyson, C. R., & Schwartz, G. G. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6384-2 · Cited by 16
Dennis, K. E., Hill, S., Rose, K. L., Sampson, U. K. A., & Hill, M. F. (2013) · Cardiovascular Pathology · doi:10.1016/j.carpath.2013.03.001 · Cited by 16
Myocardial lesions after long-term administration of methamphetamine in rats
Yi, S., Ren, L., Yang, T., Liu, L., Wang, H., & Liu, Q. (2008) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(09)60046-8 · Cited by 16
Anthracycline and trastuzumab in breast cancer treatment.
Untch, M., Himsl, I., Kahlert, S., Lueck, H.-J., Eidtmann, H., du Bois, A., Meerpohl, H. G., Thomssen, C., Harbeck, N., Jackisch, C., et al. (2004) · PubMed · Cited by 12
Morphometric and biochemical characteristics of short-term effects of ethanol on rat cardiac muscle
Mihailovic, D., Nikolić, J., Bjelakovic, B. B., Stanković, B. N., & Bjelaković, G. (1999) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(99)80137-7 · Cited by 9
mtDNA damage in the development of heart failure
Lombardi, A. A., & Elrod, J. W. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00475.2015 · Cited by 9
Alcoholic cardiomyopathy: the effect of ethanol and acetaldehyde on cardiac protein synthesis.
Schreiber, S. S., Oratz, M., & Rothschild, M. A. (1975) · PubMed · Cited by 9
Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis
Singh, S., Loke, Y. K., & Furberg, C. D. (2007) · JAMA · doi:10.1001/jama.298.10.1189 · Cited by 5
Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?
Szebeni, A., Szentandrássy, N., Pacher, P., Simkó, J., Nánási, P. P., & Kecskeméti, V. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796642364 · Cited by 3
Self-citation
Cited by
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Herrmann, J. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0348-1 · Cited by 747
Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Designing nanozymes for in vivo applications
Zhang, R., Jiang, B., Fan, K., Gao, L., & Yan, X. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00205-1 · Cited by 360
Zhao, L., Qi, Y., Xu, L., Tao, X., Han, X., Yin, L., & Peng, J. (2018) · Redox Biology · doi:10.1016/j.redox.2017.12.013 · Cited by 344
Metadata
- Authors
- Varga, Z. V., Ferdinandy, P., Liaudet, L., & Pacher, P.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2015-11
- Volume
- 309
- Issue
- 9
- Pages
- H1453-H1467
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2196197543
- Cited by
- 531
- References
- 169
- FWCI
- 14.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.